131 related articles for article (PubMed ID: 21868137)
1. Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils.
Calışkan B; Luderer S; Özkan Y; Werz O; Banoglu E
Eur J Med Chem; 2011 Oct; 46(10):5021-33. PubMed ID: 21868137
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.
Sud'ina GF; Pushkareva MA; Shephard P; Klein T
Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):99-108. PubMed ID: 18280718
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
[TBL] [Abstract][Full Text] [Related]
4. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
Abdelgawad MA; Labib MB; Abdel-Latif M
Bioorg Chem; 2017 Oct; 74():212-220. PubMed ID: 28865292
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
6. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase.
Araico A; Terencio MC; Alcaraz MJ; Domínguez JN; León C; Ferrándiz ML
Life Sci; 2006 May; 78(25):2911-8. PubMed ID: 16360707
[TBL] [Abstract][Full Text] [Related]
7. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
8. New inhibitors of 5-lipoxygenase catalytic activity based on 2-(3-methylphenyl)propanoic acid and 4-substituted morpholine derivatives.
Khayrullina VR; Taipov IA; Veselovsky AV; Shcherbinin DS; Gerchikov AY
Biochemistry (Mosc); 2014 Apr; 79(4):376-84. PubMed ID: 24910210
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors.
Lai Y; Ma L; Huang W; Yu X; Zhang Y; Ji H; Tian J
Bioorg Med Chem Lett; 2010 Dec; 20(24):7349-53. PubMed ID: 21055929
[TBL] [Abstract][Full Text] [Related]
10. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase.
Li Y; Chen SH; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Mar; 19(6):2074-83. PubMed ID: 21349729
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 3-(4-bromophenyl)-6-nitrobenzo[1.3.2]dithiazolium ylide 1,1-dioxide as a novel dual cyclooxygenase/5-lipoxygenase inhibitor that also inhibits tumor necrosis factor-alpha production.
Chen CS; Tan CM; Huang CH; Chang LC; Wang JP; Cheng FC; Chern JW
Bioorg Med Chem; 2010 Jan; 18(2):597-604. PubMed ID: 20056549
[TBL] [Abstract][Full Text] [Related]
12. Outstanding Anti-inflammatory Potential of Selected Asteraceae Species through the Potent Dual Inhibition of Cyclooxygenase-1 and 5-Lipoxygenase.
Chagas-Paula DA; Oliveira TB; Faleiro DP; Oliveira RB; Costa FB
Planta Med; 2015 Sep; 81(14):1296-307. PubMed ID: 26227502
[TBL] [Abstract][Full Text] [Related]
13. Trihydroxyflavones with antioxidant and anti-inflammatory efficacy.
Gomes A; Couto D; Alves A; Dias I; Freitas M; Porto G; Duarte JA; Fernandes E
Biofactors; 2012; 38(5):378-86. PubMed ID: 22806885
[TBL] [Abstract][Full Text] [Related]
14. Different forms of vitamin E and metabolite 13'-carboxychromanols inhibit cyclooxygenase-1 and its catalyzed thromboxane in platelets, and tocotrienols and 13'-carboxychromanols are competitive inhibitors of 5-lipoxygenase.
Park NY; Im S; Jiang Q
J Nutr Biochem; 2022 Feb; 100():108884. PubMed ID: 34710615
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL
Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of COX-2 and NF-κB1 Gene Expression, NO Production, 5-LOX, and COX-1 and COX-2 Enzymes by Extracts and Constituents of Onopordum acanthium.
Lajter I; Pan SP; Nikles S; Ortmann S; Vasas A; Csupor-Löffler B; Forgó P; Hohmann J; Bauer R
Planta Med; 2015 Sep; 81(14):1270-6. PubMed ID: 26383017
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation.
Schühly W; Hüfner A; Pferschy-Wenzig EM; Prettner E; Adams M; Bodensieck A; Kunert O; Oluwemimo A; Haslinger E; Bauer R
Bioorg Med Chem; 2009 Jul; 17(13):4459-65. PubMed ID: 19481465
[TBL] [Abstract][Full Text] [Related]
18. Marginally designed new profen analogues have the potential to inhibit cyclooxygenase enzymes.
Gülcan HO; Ünlü S; Dimoglo A; Şahin Y; Esiringu İ; Erçetin T; Öz D; Şahin MF
Arch Pharm (Weinheim); 2015 Jan; 348(1):55-61. PubMed ID: 25581679
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A
Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277
[TBL] [Abstract][Full Text] [Related]
20. Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase.
Karg EM; Luderer S; Pergola C; Bühring U; Rossi A; Northoff H; Sautebin L; Troschütz R; Werz O
J Med Chem; 2009 Jun; 52(11):3474-83. PubMed ID: 19492852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
